Relative Bioavailability of Dextromethorphan Syrup in Comparison to Dextromethorphan Soft Pastilles in Healthy Male and Female Subjects

NCT02191709 ↗

Phase 1 Completed 18 enrolled Boehringer Ingelheim

RandomizedCrossoverOpen-labelTreatment

Summary

Study to investigate the relative bioavailability of orally administered dextromethorphan syrup in comparison to dextromethorphan (DMP) soft pastilles in healthy male and female subjects who are extensive metabolisers for CYP 2D6

Timeline

Start: 2009-01
Primary completion: 2009-02
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Dextromethorphan	Unknown	21 mg	Oral

Indications

No indication recorded.